AI assistant
Streamex Corp. — Director's Dealing 2022
Sep 2, 2022
35540_dirs_2022-09-02_7500af87-0341-45bf-ae53-9374bafb335c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2022-09-01
Reporting Person: LONDONER KENNETH L (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-01 | Common Stock | P | 17240 | $1.0849 | Acquired | 1824804 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1181324 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.02 to $1.15, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2: The reporting person is the beneficial owner of Endicott Management Partners, LLC.